Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Cancers|June 22, 2023
A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and InvasionElisabetta Michielon, Marta López González, Dorian A Stolk, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balanceTanja D de Gruijl, Claudia C Sombroek, Sinéad M Lougheed, et al.Immunotherapy|September 15, 2011
Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibitionHester van Cruijsen, Dinja Oosterhoff, Jelle J Lindenberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2013
Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycansDinja Oosterhoff, Moniek Heusinkveld, Sinéad M Lougheed, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2019
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trialCharlotte M Huijts, Sinéad M Lougheed, Zuhir Bodalal, et al.Atherosclerosis|December 30, 2011
S-Adenosylhomocysteine induces apoptosis and phosphatidylserine exposure in endothelial cells independent of homocysteineJessica A Sipkens, Nynke E Hahn, Henk J Blom, et al.Journal for Immunotherapy of Cancer|July 22, 2015
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumabSaskia Jam Santegoets, Anita Gm Stam, Sinéad M Lougheed, et al.Vaccine|May 15, 2003
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activationJoana G Brandão, Rik J Scheper, Sinéad M Lougheed, et al.Blood|July 2, 2002
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursorsAllan J Masterson, Claudia C Sombroek, Tanja D De Gruijl, et al.Cancer Immunology, Immunotherapy : CII|November 11, 2018
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinomaCharlotte M Huijts, Inge M Werter, Sinéad M Lougheed, et al.Pageof 5